Diagnostics company Biodesix had its IPO on October 28, opening at $18 per share but slipping to about $13.50 over several days, giving the company a market cap of $360M.
- See the company's website here, here.
- See the S-1 here at SEC or here in the cloud.
- See the stock ticker at Yahoo Finance here.
- See an article by an investment watcher at Seeking Alpha here.
